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the hypothesis that 5-HT4 receptor
agonists are rapid and efficacious anti-
depressant agents. However, these
agents will require extensive testing in
clinical trials for confirmation, due to
limitations inherent in rodent models
of depression and antidepressant re-
sponse and because of potential side
effects. It seems likely that these new
results presented in this report will
stimulate efforts to develop safe 5-
HT4 agonists that enter the brain and
that can be used to further test this
hypothesis in preclinical and ultimately
clinical trials that could lead to a much
needed novel, rapid, and improved
class of antidepressants.
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In two manuscripts published in Neuron (Beg et al. and Wegmeyer et al.) and one published in Cell
(Iwasato et al.), investigators have found that a particular GAP, a-chimaerin, is required in vivo for
ephrinB3/EphA4-dependent motor circuit formation.The diversity of signaling molecules
has long fascinated scientists and sug-
gested the possibility that particular
proteins might be required for specific
cellular events. However, examples of
signal transduction proteins acting
only during particular cellular events
have been few and far between. Now,
three papers provide a beautiful in vivo
example of a specific function for a
particular signaling molecule.Together,
the three manuscripts are striking for
the extent that they each describe
a similar set of results but use indepen-
dent approaches to do so: one group
began by identifying a spontaneous
mouse mutant (Iwasato et al., 2007),
a second used a yeast two-hybrid
screen (Wegmeyer et al., 2007), and
a third used a screen for protein-
protein interactions (Beg et al., 2007).While each paper offers its own strong
evidence for the role of a-chimaerin in
mediatingephrinB3/EphA4-dependent
motor circuit formation, together these
manuscripts provide a compelling and
unusually comprehensive picture of an
essential role for a particular GAP.
Small GTPases in the Rac, Rho, and
Cdc42 families act as molecular swi-
tches in signaling pathways, with the
GTP-bound ‘‘ON’’ state and GDP-
bound ‘‘OFF’’ state. Regulating the
cycle between ON and OFF are over
70 small RhoGTPase-activating pro-
teins (GAPs) in the mammalian ge-
nome, with 12 known to have specific
activity for Rac. Chimaerins are Rho-
GAPs with specific activity for Rac
that contain a C1 domain that allows
them to bind phorbol esters (Yang
and Kazanietz, 2007). There are twoNeuron 55, Sea-chimaerins and two b-chimaerins
made as alternatively spliced products
of two genes. a2- and b2-chimaerin
also contain SH2 domains that enable
them to bind phosphorylated tyrosine
residues. The a-chimaerin GAPs are
expressed in brain and linked to axon
guidance (Diaz et al., 2002), sema-
phorin signaling (Brown et al., 2004),
dendritic spine development (Buttery
et al., 2006), and the NMDAR (Van de
Ven et al., 2005). These properties
made chimaerin an interesting candi-
date for regulating axonal growth in
the nervous system.
Work from a number of laboratories
has identified a specific role of eph-
rinB3/EphA4 forward signaling in the
formation of the motor circuit between
neurons in layer 5 of motor cortex and
the principle motor neurons in theptember 6, 2007 ª2007 Elsevier Inc. 681
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PreviewsFigure 1. Model for a2-Chimaerin Activity in EphrinB3/EphA4 Forward Signaling
(A) EphrinB3 mediated axon guidance via EphA4 and a2-chimaerin in axonal process of cortical
projection neurons.
(B) EphrinB3 binds to EphA4. a2-Chimaerin binds to EphA4, and, in the presence of ephrinB3, its
RAC-inactivating activity is increased. Chimaerin’s RAC-inactivation activity is also modulated
with Nck2. EphA4s interact with RhoGEFs that may participate in other aspects of growth cone
guidance.
(C) Loss of ephrinB3, EphA4, or a-chimaerin leads to defects in gait resulting from axonal projec-
tion defects. Interestingly, only defects in guidance due to ephrinB3/EphA4 forward signaling are
phenocopied by the loss of a-chimaerin.lumbar spinal cord (Dottori et al., 1998;
Coonan et al., 2001; Kullander et al.,
2001; Kiehn and Butt, 2003). Mice
with mutations to either of these pro-
teins exhibit a hopping rabbit-like
gait where both hindlimbs move to-
gether—arising from the failure of
cortical motor axons to innervate only
contralateral motor neurons in the spi-
nal cord and from defects in spinal in-
terneuron axonal projections (Figures
1A and 1C). These defects appear to
be due to the failure of these axons
to respond to an ephrinB3 repulsive
guidance cue along the midline of the
spinal cord that allows axons to inner-
vate both left and right motor neurons
(Kullander et al., 2001, 2003). More-
over, ephrin-Eph signaling induces
growth cone collapse that appears to
be mediated via regulation of small
GTPase activity (Kullander and Klein,
2002; Cowan et al., 2005; Sahin
et al., 2005).
In the manuscript by Iwasato et al.
from the RIKEN institute (Iwasato
et al., 2007), the authors began by not-
ing a rabbit-like gait in a Chat-Cre line682 Neuron 55, September 6, 2007 ª200of mice that they generated. Thinking
that the insertion of their CRE con-
struct was the cause, they were sur-
prised to learn that the mutation segre-
gated from the CRE, indicating that
a spontaneous mutation was causing
the phenotype. They determined that
the gait defect in the miffy mice was
likely due to defects in the motor circuit
arising from defects in cortical spinal
tract projections (CST). This mispro-
jection resulted in an abnormal rhyth-
mic activity of flexors and tensors
reminiscent of that seen in mice lack-
ing EphA4. The authors then isolated
the mfy locus using microsatellites
and single-nucleotide polymorphisms
(SNPs) to a 3.27 Mb region on chromo-
some 2. Of the 30 genes in that region,
ten were ruled out because mice lack-
ing these genes were known not to
have defects in gait. Fortunately for
the authors, only one of the 20 remain-
ing genes generated different sized
transcript when amplified with RT-
PCR—a-chimaerin. The region affec-
ted in the miffy mutation resulted in
a loss of 58 amino acids in both a1-7 Elsevier Inc.and a2-chimaerin and generated pro-
teins that lacked GAP activity in vitro.
To demonstrate that this mutation
was the cause of the defects in motor
circuit formation, Iwasato et al. then
undertook to rescue the expression
of a-chimaerin using a bac-transgenic
rescue in the miffy/ mice and attem-
pted to phenocopy their spontaneous
mutation by making a targeted dele-
tion of a-chimaerin. Likely due to its
low sub-wild-type level of expression,
the bac-transgenic gave a partial res-
cue, but knockout of the locus phe-
nocopied the spontaneous mutation,
indicating that miffy is likely due to
a mutation in a-chimaerin.
Iwasato et al. then began to examine
whether a-chimaerin and EphA4 might
interact. Immunocytochemistry revea-
led that a-chimaerin and EphA4 pro-
teins colocalize in developing CST
axons in vitro. Moreover, Iwasato et al.
were able to demonstrate that a2-
chimaerin and EphA4 coimmunopreci-
pitate when coexpressed in HEK293T
cells, in neurons, and from brain lysates
of mice. By making mutations to a2-
chimaerin and EphA4, they found in
HEK293T cells that the interaction ap-
pears to be EphA4 kinase independent
and relies on the C-terminal domain of
a2-chimaerin. The interaction between
EphA4 and a2-chimaerin also appears
to be functional: a2-chimaerin can
inactivate Rac downstream of kinase-
active EphA4 when these proteins
are coexpressed in COS cells and
then stimulated with a soluble form
of ephrinB3 (ephrinB3-Fc). Finally, the
authors use an RNAi knockdown ap-
proach to demonstrate that motor
cortex axons expressing less a2-chi-
maerin are less sensitive to ephrinB3-
dependent growth cone collapse.
The two papers published in Neuron
begin with a more traditional appro-
ach, with both groups first demon-
strating that a2-chimaerin or domains
of this protein interact with Ephs. Us-
ing a yeast two-hybrid screen with
a2-chimaerin SH2, Wegmeyer et al.
identified EphA4 and EphB1 as a2-
chimaerin-interacting proteins (Weg-
meyer et al., 2007). This group then
generated two mice with mutations to
the a-chimaerin locus: a conventional
knockout and a knockin with a point
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Previewsmutation in the C1 domain. The
knockin mutation resulted in a loss of
a1-chimaerin expression and reduc-
tion of a2-chimaerin transcript. Similar
to what Iwasato et al. reported, hetero-
zygous animals had no phenotype,
and homozygous mice of both geno-
types displayed defects in gait. Exam-
ination of the CST in both lines of mu-
tant mice revealed increased axonal
recrossing and a decrease in the size
of the dorsal funiculus. Recording mo-
tor output from lumbar dorsal roots re-
vealed a loss of motor coordination
that was similar to that seen in the
mice generated by the Iwasato et al.
group. Neurons from mice lacking
a-chimaerin had impaired growth
cone collapse following ephrinB3 or
ephrinA1 stimulation. Moreover, con-
sistent with the data from all three
papers, while loss of a-chimaerins
resulted in defects in CST axonal pro-
jections, axons that were dependent
on EphA4 reverse signaling were unaf-
fected.
Having demonstrated that mice
lacking a-chimaerin have defects in
the CST projection and neuronal
growth cones from these animals fail
to respond robustly to ephrin treat-
ment, Wegmeyer et al. next examined
how EphA4 might interact with and
regulate a-chimaerins. Unlike Iwasato
et al., Wegmeyer et al. were not able
to coimmunoprecipitate a-chimaerin
with EphA4; therefore, they turned to
a GST-pulldown assay. Using this as-
say, Wegmeyer et al. determined that
both a1- and a2-chimaerin can bind
to EphA4 with a complex series exper-
imental results. a1-Chimaerin appears
to bind EphA4 strongly, in the kinase
domain, but does not require the ki-
nase to be active. a2-Chimaerin, on
the other hand, appears to bind to
EphA4 both through its SH2 domain
and via a second kinase-independent
interaction. Because they interact, the
authors then asked whether EphA4
might phosphorylate a-chimaerin.
Both isoforms of a-chimaerin are
phosphorylated in 293FT cells when
coexpressed with EphA4, and a muta-
tion of three different tyrosine residues
(y202, y303, y333) on a2-chimaerin
reduces its phosphorylation, suggest-
ing that EphA4 phosphorylates thesesites. Consistent with a role of EphA-
dependent regulation of a2-chimaerin,
EGFP-tagged a2-chimaerin overex-
pressed in neurons becomes phos-
phorylated following soluble ephrinA1
activation of EphA receptors.
The Wegmeyer et al. study impli-
cates the adaptor proteins Nck1 and
Nck2 as potentially important in the
ephrin/EphA4/a2-chimaerin pathway
by showing that these proteins can in-
teract with full-length a2-chimaerin,
but not with a1-chimaerin or mutant
forms of a2-chimaerin that lack an
SH2 domain. The presence of Nck2
negatively regulates the RacGAP ac-
tivity of only a2-chimaerin in the pres-
ence of EphA4. While interpretation
of these results was limited because
the authors could not control the ex-
pression of each protein, the results
demonstrate that EphA4, a2-chi-
maerin, and Nck2 can act in a con-
certed fashion on Rac activity.
The third paper, by Beg et al. from
Columbia University (Beg et al.,
2007), uses affinity chromatography
with solublized neuronal membrane
proteins on an immobilized recombi-
nant a2-chimaerin SH2 domain and
GST-pulldown assays in HEK293T
cell lysates to identify a number of
phospho-tyrosine proteins as potential
a2-chimaerin interactors. One of these
interacting molecules was EphA4. The
SH2 domain of a2-chimaerin fused to
GST was able to pull down EphA4
and EphB1, but not TrkA. The SH2
domain interaction required EphA4
kinase activity and likely occurred via
interaction with the juxtamembrane
tyrosines. While the authors could
not demonstrate that EphA4 and a2-
chimaerin coimmunoprecipitated, they
did note that coexpression of EphA4
and a2-chimaerin led to a2-chimaerin
phosphorylation. In contrast to the ex-
periments from Wegmeyer et al., Beg
et al. found that the a2- but not the
a1-chimaerin interaction with EphA4
required EphA4 kinase activity.
To examine the in vivo significance
of a2-chimaerin, Beg et al. used a
gene-trap approach that enabled
them to substantially reduce a2-
chimaerin expression while leaving
a1-chimaerin expression at nearly
wild-type levels. The authors firstNeuron 55, Sepasked whether axons from these mu-
tant animals would still respond to
ephrinA5-Fc treatment normally and
display growth cone collapse. Consis-
tent with a role of a2-chimaerin alone
in EphA-mediated growth cone col-
lapse and reports from Iwasato et al.
using siRNA, axons from motor cortex
explants of mice lacking a2-chimaerin
were significantly less responsive to
ephrinA5 than controls.
Beg et al. then demonstrated that
the loss of a2-chimaerin generated
a phenotype strikingly similar to that
seen in animals lacking EphA4 and to
the reports by the other two groups ex-
amining the a1- and a2-chimaerin mu-
tant animals. Gene-trap a2-chimaerin
mice showed defective gait, increased
CST axon crossing, and increased
crossing of spinal interneurons. Then,
in an elegant series of experiments,
Beg et al. demonstrated a genetic
interaction between EphA4 and a2-
chimaerin by showing that double-
heterozygous mice (a2-chimaerin+/,
EphA4+/) also have enhanced spinal
interneuron axon crossing compared
to the single-heterozygous mutants
and similar to that seen in the a2-
chimaerin mutant. These experiments
provide strong genetic evidence for
EphA4 and a2-chimaerin interaction.
Each group conducted a similar se-
ries of experiments to demonstrate
that the loss of a-chimaerin generates
a phenotype similar to that seen with
loss or disruption of EphA4. In the
end, these three papers paint a com-
pelling picture of a molecule that is es-
sential for a particular aspect of EphA4
receptor signaling (Figure 1). Overall,
the data from these three papers fit to-
gether nicely, though there are a few
places, largely in the biochemical anal-
ysis, where there is some disagree-
ment. In most cases, these differences
are most likely due to differences in
methodology. In any case, the major
findings are in agreement. Whether
other GAPs and GEFs act so specifi-
cally remains to be determined; mean-
while, these papers provide a compre-
hensive and exciting picture of how
a widely expressed signaling molecule
can be essential for particular events.
There are a number of new questions
that are raised by this work. Is axontember 6, 2007 ª2007 Elsevier Inc. 683
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Previewsguidance generated by a balance be-
tween GAP and GEF activity? How of-
ten do specific GAPs act in particular
cells? Do they act sequentially within
a signaling cascade? If high levels of
specificity do exist, rather than ex-
pecting that loss of signaling proteins
will generate dramatic phenotypes,
we will have to re-examine previously
generated models for more specific
and subtle phenotypes that point to
the essential function of other widely
expressed signaling proteins.
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